Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions.

Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, Mauviel A, Böhm M (2010)

In: Journal of Biological Chemistry, 285(1).

Research article (journal)

Incremental build-up food challenge--a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic urticaria.

Bunselmeyer B, Laubach HJ, Schiller M, Stanke M, Luger TA, Brehler R (2009)

In: Clinical and Experimental Allergy, 39(1).

Research article (journal)

alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?

Kokot A, Sindrilaru A, Schiller M, Sunderkötter C, Kerkhoff C, Eckes B, Scharffetter-Kochanek K, Luger TA, Böhm M (2009)

In: Arthritis and Rheumatism, 60(2).

Research article (journal)

Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin.

Kokot A, Metze D, Mouchet N, Galibert MD, Schiller M, Luger TA, Böhm M (2009)

In: Endocrinology, 150(7).

Research article (journal)

[Psychosocial issues in outpatient care of acne vulgaris]

Hensen G, Schiller M, Luger TA, Hensen P (2009)

In: Das Gesundheitswesen, 71(7).

Research article (journal)

Publications

Contact

Top-Links

Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, Mauviel A, Böhm M (2010) In: Journal of Biological Chemistry, 285(1). Research article (journal)
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Kuhn A, Meuth AM, Bein D, Amler S, Beissert S, Bohm M, Brehler R, Ehrchen J, Grundmann S, Haust M, Ruland V, Schiller M, Schulz P, Stander S, Sauerland C, Kopcke W, Luger TA, Bonsmann G (2010) In: British Journal of Dermatology, 163(4). Research article (journal)
Incremental build-up food challenge--a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic urticaria. Bunselmeyer B, Laubach HJ, Schiller M, Stanke M, Luger TA, Brehler R (2009) In: Clinical and Experimental Allergy, 39(1). Research article (journal)
Predisposing factors of actinic keratosis in a North-West German population. Hensen P, Müller ML, Haschemi R, Ständer H, Luger TA, Sunderkötter C, Schiller M (2009) In: European Journal of Dermatology, 19(4). Research article (journal)
alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma? Kokot A, Sindrilaru A, Schiller M, Sunderkötter C, Kerkhoff C, Eckes B, Scharffetter-Kochanek K, Luger TA, Böhm M (2009) In: Arthritis and Rheumatism, 60(2). Research article (journal)
The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma? Tsianakas A, Schiller M, Luger TA, Sunderkötter C (2009) In: Journal der Deutschen Dermatologischen Gesellschaft, 7(8). Research article (journal)
Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Kokot A, Metze D, Mouchet N, Galibert MD, Schiller M, Luger TA, Böhm M (2009) In: Endocrinology, 150(7). Research article (journal)
Adjuvant interferon therapy and rheumatoid arthritis--a contraindication? Tsianakas A, Schiller M, Luger TA, Sunderkoetter C (2009) In: Acta Oncologica, 48(3). Research article (journal)
[Psychosocial issues in outpatient care of acne vulgaris] Hensen G, Schiller M, Luger TA, Hensen P (2009) In: Das Gesundheitswesen, 71(7). Research article (journal)
Targeted-inhibition of TGF-beta 2 by Trabedersen (AP 12009) for the treatment of malignant melanoma and other malicious tumours Tsianakas A, Sunderkotter C, Luger TA, Schiller M, Schmaus S, Heinrichs H, Schlingensiepen KH (2009) In: Journal der Deutschen Dermatologischen Gesellschaft, 7(11). Research article (journal)